Market Segmentation

• By Test – Panorama and Vistara; MaterniT GENOME, MaterniT 21 PLUS, informaSeq, Verifi and Verifi Plus Prenatal Tests; Harmony Test; NIFTY Test and NIFTY Test Pro; QNatal Advanced; PrenaTest, GeneSafe, and PrenatalSAFE; Bambni Test; IONA and Sage; and Others
• By Platform – PCR, Next-Generation Sequencing, and Others
• By Method – cfDNA and FCMB
• By End User – Hospitals, Clinics, Diagnostic Labs, and Others
• By Application – Trisomy Detection, Microdeletion Detection, Sex Chromosome Aneuploidy Detection, Others

Regional Segmentation

• North America – U.S., Canada
• Europe – Germany, U.K., France, Italy, Switzerland, Spain, Netherlands, Belgium, Russia, Poland, Denmark, Sweden, and Rest-of-Europe
• Asia-Pacific – China, Australia, Japan, India, South Korea, Hong Kong, Malaysia, Indonesia, Vietnam, Thailand, Philippines, and Rest-of-Asia-Pacific
• Latin America
• Rest-of-the-World

Market Growth Drivers

• Increased Emphasis on Early Detection and Prevention
• Availability of Advanced Screening Technologies
• Increasing Consumer Demand
• Shifting of Reimbursement Policies Toward More Genetics Coverage
• High Incidence Rate of Down’s Syndrome
• Rising Average Maternal Age
• Increasing Prevalence of Genetic and Congenital Disorders

Market Challenges

• Stringent Regulatory Guidelines and Ethical Hurdles
• Limitations of NIPT
• Lack of Awareness Among Consumers
• Alternative Screening and Testing Methods

Market Opportunities

• Capitalizing on the Potential Presented by the Emerging Markets in Asia
• Availability of Direct-to-Consumer Tests
• Focus on Pre-Implantation Genetic Diagnosis

Key Companies Profiled

Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd, PerkinElmer, Inc., Quest Diagnostics Incorporated, Illumina, Inc., Myriad Genetics, Inc., BGI, CENTOGENE N.V., Laboratory Corporation of America Holdings, MedGenome Inc., Annoroad Gene Technology, Natera, Inc., Yourgene Health PLC, Next Biosciences, Eurofins Scientific

Key Questions Answered in this Report:

• What is the importance of NIPT, and what are the different NIPT products/services available in the market? What are the different methods of NIPT, and what are the benefits and risks associated with it?
• What are the major technological advancements witnessed by the global NIPT market in the past four years, and what is the future scope of the market? What are the key trends of the global NIPT market as per the year 2020, and how is the market evolving currently?
• What was the market size of the global NIPT market in 2020, and what is the market size anticipated to be in 2031? What is the expected growth rate of the global NIPT market during the period 2021-2031?
• What is the market scenario and growth potential of different regions of the world, including North America, Europe, Asia-Pacific, and Rest-of-the-World?
• What are the major drivers, challenges, and opportunities of the global NIPT market?
• Who are the major key players of the global NIPT market? How much market share does each of these players occupy in the market in 2019? Which companies are anticipated to be highly disruptive in the future, and why?
• What is the regulatory scenario of the global NIPT market? What are the initiatives implemented by different governmental bodies and guidelines put forward to regulate the commercialization of NIPT products?
• What is the average NIPT cost in different countries? What is the reimbursement scenario of the global NIPT market, and what is the reimbursement rate in different countries of the world, including countries of North America, Latin America, Asia-Pacific, Europe, and the Middle East and Africa?
• What is the funding scenario of the market with respect to institutional and academic funding? What is the patent landscape of the market, and which companies stand out for registering the greatest number of patents?
• What are the key developmental strategies implemented by the key players of the global NIPT market to sustain the competition of the market? What is the percentage share of each of the key players in different key developmental strategies?
• What are the different NIPT tests available in the market, and which test type dominates the market in 2020 and 2031 in terms of value and volume?
• What is the global market size (by value and volume) of different types of products of the global NIPT market in 2020? What are the key trends of the market with respect to different kits, assays, and which product is expected to dominate the market in 2031?
• What are the different platforms supported by NIPT products? Which technology type dominated the market in 2020 and is expected to dominate in 2031 (by value and volume)?
• What are the different applications associated with NIPT? What was the contribution of each of the application areas in the global NIPT market for the period between 2021 and 2031 (by value and volume)?
• What is the global NIPT market size (by value and volume) based on different methods? Which method is currently leading the market and why? Which method is expected to lead the market during the forecast period?
• Who are the different end users of the global NIPT market (by value and volume)? Which end-user type is the major contributor of revenue in the market?

Market Overview

Non-invasive prenatal testing (NIPT) is a sophisticated method used for the screening of chromosomal abnormalities developing in the fetus. Currently, NIPT is considered a valuable test for the pregnant women to provide cost-effective and highly efficient early diagnosis of genetic disorders. The growth in the market is attributed to the increasing reimbursement policies and insurance coverage across the globe.

Further, the continued significant investments for genome sequencing by healthcare companies to meet the industry demand and the growing incidence of genetic disorders are the prominent factors propelling the growth of the global NIPT market.

Advancements in genome sequencing technologies reduce turnaround time and the complexity of diagnosis with next generation sequencing (NGS). The NGS technology provides several opportunities to develop the non-invasive diagnostic procedures for an early and accurate detection of various genetic disorders.

The life science industry is witnessing significant growth of NIPT tests developed using the NGS technology. Several biotechnology companies are now indulging in the research and development of such NGS-based NIPT products. Furthermore, the advent of genome sequencing technologies in the life science industry has enabled the companies to detect the genetic diseases at an early stage and provide accurate results to remain competitive in the market.

Our healthcare experts have found global NIPT market as one of the most rapidly evolving markets amongst the other prenatal testing industries. The purpose of this study is to gain a holistic view of the NIPT market in terms of various influencing factors, such as recent trends, regulatory requirements, and technological advancements of the market.

The scope of this report constitutes a detailed study of the tests associated with the global NIPT market across different regions. The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well-informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering the market.

The report includes an in-depth examination of the key players and recent developments taking place in this market. Moreover, the report includes chapters on market dynamics (market drivers, opportunities, and challenges) and industry analysis as well.

Also, aims at answering various aspects of the global NIPT market with the help of the key factors driving the market, restraints, and challenges that can inhibit the overall market growth and the current growth opportunities that are going to shape the future trajectory of the market expansion

Within the research report, the market has been segmented into ‘platforms,’ ‘tests,’ ‘methods,’ ‘applications,’ ‘end-user’, and ‘regions.’. Each of these segments covers the inclination of the market revenue, underlying patterns, snapshot of the market over the projected years, and trends by using analytics on the primary and secondary data obtained.

Competitive Landscape

The NIPT market is currently at a blooming phase, with the presence of various juggernauts such as Laboratory Corporation of America Holdings, F. Hoffmann-La Roche Ltd, Illumina, Inc., Agilent Technologies, Inc., BGI, and PerkinElmer Inc., as well as other medium and small-medium enterprises, that are offering wide range of NIPT products and services in the market.

Several companies are attempting to enter the market and sustain themselves in the competition by adopting different strategies varying from partnerships and collaborations to business expansions and product launches.

Related Report: Global Non-Invasive Liquid Biopsy Market: Focus on Offering, Sample, Application, Technology, End Users, Country Data (16 Countries), and Competitive Landscape – Analysis and Forecast, 2021-2031

The post Global Non-Invasive Prenatal Testing Market: Focus on Method, Test, Platform, End User, Application and Country Analysis – Analysis and Forecast, 2020-2031 first appeared on CRI Report.

Market Segmentation

• Product – Systems, Media and Reagents, Accessories and Consumables
• Type – Conventional IVF, IVF with Intracytoplasmic Sperm Injection (ICSI)
• Procedure – Fresh Donor, Fresh Non-donor, Frozen Donor, Frozen Non-donor
• End User – Commercial Labs, Fertility Clinics, Hospital Systems, Other End Users

Regional Segmentation

• North America – U.S., Canada
• Europe – Germany, France, Italy, U.K., Spain, Russia, Netherlands, Rest-of-Europe
• Asia-Pacific – Japan, China, India, South Korea, Australia, Singapore, Rest-of-APAC
• Latin America – Brazil, Mexico
• Rest-of-the-World

Growth Drivers

• Growth in Median Age of First-Time Motherhood and Declining Fertility Rates
• High Success Rate of IVF Treatment
• Increasing Demand for Infertility Treatment to Support Aging Population
• Impact of Fertility Tourism

Market Challenges

• Unaffordable Cost of Assisted Reproductive Techniques (ART) and Genetic Testing in Low- and Middle- Income Countries
• Lack of Guidelines and Regulations, and Low Awareness of IVF Treatment in Some Under-Developed and Developing Nations
• Ethical Issues and Social Justice

Market Opportunities

• Technological Advancements of Time-Lapse Technology
• Advances in Embryo Biopsy and Genetic Screening

Key In-Vitro Fertilization Companies Profiled

Suppliers – Cooper Companies Inc., Vitrolife AB, Illumina, Inc., Agilent Technologies, Inc., Cook Medical Inc., Fujifilm Irvine Scientific Inc., F. Hoffmann-La Roche Ltd., GE Healthcare, Abbott Laboratories, Thermo Fisher Scientific Inc., Merck KGaA, Esco Micro Pte. Ltd., IVFtech APS, and Kitazato Corporation.

Service Providers – CARE Fertility, Laboratory Corporation of America Holdings, Genea Limited, Natera, Inc., Invitae Corporation, Kaiser Permanente, Progyny, Inc., Boston IVF, and Monash IVF Group

Key Questions Answered in this Report:

• What is in-vitro fertilization?
• What are different types of systems, media, and reagents available in the market, and what are they used for? What are the key companies offering these devices and reagents? What would be the global market value for each of these systems, media, and reagents for the time between 2020 and 2030?
• Based on systems, which IVF system type is anticipated to witness a massive rise in the demand in the forecast period? Based on reagents, which reagent type is anticipated to witness a massive rise in the demand in the forecast period?
• What are the different testing services involved in IVF procedures, and what are the key companies offering them? What would be the global market value for services for the period 2019-2030?
• What are the major drivers, challenges, and opportunities of the global IVF market?
• What are the key developmental strategies implemented by the key players to stand out in this market?
• What are the leading companies dominating the global IVF market? What is the share of these companies in the global IVF market?
• What are the regulations pertaining to the global IVF market? What initiatives are implemented by different government bodies regulating the development and commercialization of IVF devices?
• By end-user type, what would the market value of the leading segments of the global IVF market be? By procedure type, what would the market value of the leading segments of the global IVF market be?
• How will each segment of the global IVF market grow during the forecast period, and what will be the revenue generated by each of the segments by the end of 2030?
• How will the industry evolve during the forecast period 2020-2030?
• What is the market scenario for the IVF services market in different regions?
• What are the key trends of different regions in the IVF market? Which country would contribute to the highest sales of the IVF market during the forecast period 2020-2030?

Market Overview

Infertility is a serious health issue worldwide, affecting approximately 8%–10% of couples worldwide. According to CDC, 2013 and Office on Women’s Health, 2019 reports, about 9% of men and 10% of women aged 15 to 44 reported infertility problems in the U.S., and according to the Reproductive Biological Endocrinology, 2015 report, around 48.5 million couples experience infertility, globally. In response to these issues, countries across the globe are striving hard to increase their fertility rates, thereby promoting high adoption of assisted reproductive technologies (ART). ART are cutting-edge technologies that help to treat infertility by manipulating sperm and/or eggs outside the human body.

The global in-vitro fertilization market consists of systems, media, and reagents, and pharmaceuticals used to carry out the entire procedure, from monitoring and stimulating a woman’s ovulatory process to the final implantation of the embryo into the concerned woman’s fallopian tube to bringing out a successful pregnancy. The increasing incidence of infertility owing to lifestyle changes, such as an increase in the median age of first-time motherhood, is a major factor contributing to the growth of the global in-vitro fertilization market.

Our healthcare experts have found in-vitro fertilization to be one of the most rapidly evolving techniques, and the global market for in-vitro fertilization is predicted to grow at a CAGR of 9.37% over the forecast period 2020-2030. An increase in the trend of delayed pregnancies, changing lifestyles in urban areas, and increased age of parenthood bolster the growth of the global IVF market. The following report presents the reader with an opportunity to unlock comprehensive insights with respect to the global IVF market and helps in forming well-informed strategic decisions. The market research study also offers a wide perspective of the different types of products and services available in the market and their impact on the healthcare sector by providing critical insights into the direction of its future expansion.

The global IVF market is largely dominated by companies such as The Cooper Companies Inc., Vitrolife AB, Cook Medical, Merck KGaA, Fujifilm Holdings Corporation, and other enterprises. Declining fertility rates, changing lifestyles in urban areas, and increased age of parenthood are expected to be the primary factors driving the growth of the global IVF market. Government funding encouraging infertility treatments in addition to the industrial revolutions and technological advancements in the ART field is further expected to accelerate the growth of the market during the forecast period 2020-2030.

Based on region, Europe is the dominating region for the global in-vitro fertilization market in the year 2019. Low fertility rates and flexible government regulations are the two most prominent factors contributing to the growth of the IVF market in Europe. In the Asia-Pacific region, China, Japan, India, Australia, and New Zealand are among the top five countries generating the highest revenues compared to other countries of the region.

Within the research report, the market is segmented based on product, services, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Competitive Landscape

The global IVF market is distributed among suppliers and service providers. Cooper Surgical, Vitrolife AB, Merck KGaA, and Cook Medical are some of the key suppliers to this market. Among the service providers, companies like Progyny, Natera, and Invitae Corp. are the major service providers offering IVF diagnostic and testing services.

The global in-vitro fertilization market is currently dominated by Cooper Companies, Inc., followed by Vitrolife AB. The market dominance of Cooper Companies, Inc. can be attributed to a large product offering in media, reagents, and consumables segments. Merck KGaA holds the third largest share, owing to its diverse range of product offerings in consumables (including media, kits, and accessories) and systems.

The post Global In-Vitro Fertilization Market: Focus on Products, Types, Procedures, and End Users, Country Data (16 Countries), and Competitive Landscape – Analysis and Forecast, 2020-2030 first appeared on CRI Report.